Skip to main content

4 Result(s)

within Jun-Hui Yu Remove this filter

and

  1. Article

    Open Access

    Correction to: Efficacy and Pharmacodynamic Target Attainment for Ceftazidime–Avibactam Off-Label Dose Regimens in Patients with Continuous or Intermittent Venovenous Hemodialysis: Two Case Reports

    **ao-Shan Zhang, Yu-Zhen Wang, Da-Wei Shi, Fang-Min Xu… in Infectious Diseases and Therapy (2022)

    Download PDF (142 KB) View Article

  2. Article

    Open Access

    Efficacy and Pharmacodynamic Target Attainment for Ceftazidime–Avibactam Off-Label Dose Regimens in Patients with Continuous or Intermittent Venovenous Hemodialysis: Two Case Reports

    Limited data are available for ceftazidime–avibactam (CZA) dosing in patients receiving renal replacement therapy, especially the data on the dosing in patients receiving intermittent hemodialysis (IHD). In th...

    **ao-Shan Zhang, Yu-Zhen Wang, Da-Wei Shi, Fang-Min Xu… in Infectious Diseases and Therapy (2022)

    Download PDF (333 KB) View Article

  3. No Access

    Article

    A multifunctional fluorescent aptamer probe for highly sensitive and selective detection of cadmium(II)

    We report a highly sensitive and selective strategy for Cd(II) assay using a singly labeled multifunctional probe consisting of a Cd(II)-specific aptamer (CAP), which acted as a recognition element for Cd(II) ...

    Yu-Feng Zhu, Yong-Sheng Wang, Bin Zhou… in Analytical and Bioanalytical Chemistry (2017)

  4. No Access

    Article

    Two Chinese pedigrees for adenomatous polyposis coli: new mutations at codon 1309 and predisposition to phenotypic variations

    Familial adenomatous polyposis (FAP) is an autosomal dominant inherited disease caused by a mutation in the adenomatous polyposis coli (APC) gene. Some studies have attempted to correlate mutations at codon 13...

    Dai-**ang Liao, Bing Li, Xue-Mei Du, Jun-Hui Yu, Hong Chang… in Familial Cancer (2014)